Skip to main content
HairCited

Ferro per Perdita di capelli da carenza di ferro

A

Basato su 73 studi (4 meta-analyses) con 30,034 partecipanti totali. I risultati sono contrastanti tra gli studi.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'ingredient\u003Diron\u0026condition\u003Diron\u002Ddeficiency\u002Dhair\u002Dloss'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

In sintesi

Iron deficiency is clearly linked to hair loss, and correcting a genuine deficiency may support hair regrowth, but iron supplementation is not universally effective for all types of hair loss.

  • 73 studies across 30,034 participants provide extensive evidence on the iron-hair loss connection
  • Low serum ferritin levels are frequently observed in patients with hair loss
  • Supplementation appears most beneficial when a true iron deficiency is documented
  • Iron supplementation without confirmed deficiency may not improve hair outcomes and can carry risks

Key Study Findings

review
[Restless leg syndrome. Diagnosis and treatment].
Dose: various vs: Placebo Effetto: None None
case-control n=90
Restless Leg Syndrome and Association with Serum NT Pro-CNP.
Dose: None vs: Placebo Effetto: NT pro-CNP significantly lower in RLS vs controls; sensitivity 80%, specificity 88.9%; serum iron lo None
cross-sectional n=150
Prevalence of Restless Leg Syndrome and Its Association With Iron Deficiency in Patients With Chronic …
Dose: None vs: Placebo Effetto: RLS prevalence 42%; serum ferritin lower in RLS (88.4 vs 126.7 ng/mL); TSAT lower (16.3% vs 22.1%); p < 0.01
review
Restless Leg Syndrome and Pregnancy.
Dose: iron supplementation, folate, dopamine agonists (non-pharmacological and pharmacological) vs: Placebo Effetto: None None
cross-sectional study n=100
Assessment of Serum Ferritin Levels in Female Patients With Telogen Effluvium.
Dose: not applicable (observational; serum ferritin measured) vs: Placebo Effetto: mean ferritin 24.30 vs 44.78 ng/mL < 0.001

Key Statistics

73

Studi

30034

Partecipanti

Mixed

A

Grado

Referenced Papers

Revista de neurologia None 8 citazioni
Southern medical journal 2025
Tremor and other … 2023 32 citazioni
Journal of the … 2019 189 citazioni
Acta dermatovenerologica Croatica … 2016 6 citazioni
Biometals : an … 2016
Sleep medicine clinics 2015 158 citazioni
Handbook of clinical … 2014 52 citazioni
Nephro-urology monthly 2014 43 citazioni
Annals of gastroenterology 2014 5 citazioni
Turkish journal of … 2014 5 citazioni
Skin pharmacology and … 2013 127 citazioni
Expert opinion on … 2012 6 citazioni
Indian journal of … 2011 75 citazioni
The Israel Medical … 2008 61 citazioni
American journal of … 2007 61 citazioni
Seminars in cutaneous … 2006 23 citazioni
The Journal of … 2003 222 citazioni
Sleep medicine reviews 2001 48 citazioni
Dermatologic clinics 1993 38 citazioni

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Dosaggi di uso comune

general:
18 mg/day (women)
deficiency:
65-200 mg elemental iron/day

Limite massimo: 45 mg/day

Dosaggi studiati nella ricerca

Dosaggio Durata Effetto N
various -- Positive --
None -- Positive 90
None -- Positive --
None -- Positive 150
iron supplementation, folate, dopamine agonists (non-pharmacological and pharmacological) -- Positive --
not applicable (observational; serum ferritin measured) -- Negative 100
None -- Neutral 113
None -- Neutral 2851

Momento migliore per l'assunzione: On an empty stomach with vitamin C for best absorption; take 2 hours apart from calcium

Safety & Side Effects

Effetti collaterali segnalati

  • Constipation (most common)
  • Nausea and stomach cramps
  • Dark or black stools
  • Iron overload with excessive supplementation (hemochromatosis risk)

Interazioni note

  • Calcium supplements and dairy (reduce iron absorption by 50-60%)
  • Proton pump inhibitors (omeprazole) and H2 blockers reduce absorption
  • Tetracycline and quinolone antibiotics (mutual absorption reduction)
  • Levothyroxine (iron reduces thyroid hormone absorption)

Livello di assunzione massimo tollerabile: 45 mg/day

Consultare sempre il proprio medico prima di iniziare qualsiasi integratore.Consultate sempre il vostro medico prima di iniziare qualsiasi integratore.

Frequently Asked Questions

Does Ferro help with Perdita di capelli da carenza di ferro?
Based on 73 studies with 30,034 participants, there is strong evidence from multiple clinical trials that Ferro may support Perdita di capelli da carenza di ferro management. Our evidence grade is A (Strong Evidence).
How much Ferro should I take for Perdita di capelli da carenza di ferro?
Studies have used various dosages. A commonly studied range is 18 mg/day (women). Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Ferro?
Reported side effects may include Constipation (most common), Nausea and stomach cramps, Dark or black stools, Iron overload with excessive supplementation (hemochromatosis risk). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Ferro and Perdita di capelli da carenza di ferro?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 73 peer-reviewed studies with 30,034 total participants. The overall direction of effect is mixed.

Related Evidence

Altri ingredienti per Perdita di capelli da carenza di ferro

Avvertenza FDA: Queste affermazioni non sono state valutate dalla Food and Drug Administration. I prodotti e le informazioni presenti su questo sito web non sono destinati a diagnosticare, trattare, curare o prevenire alcuna malattia. I gradi di evidenza presentati si basano sulla nostra analisi della ricerca pubblicata e sottoposta a revisione paritaria e non costituiscono consulenza medica. Consultate sempre il vostro medico prima di iniziare qualsiasi regime di integrazione.